ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Clinical trial NCT05532722 · COMPLETED

Trial details

NCT number: NCT05532722
Sponsor: Abcuro, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-cell Large Granular Lymphocytic Leukemia

Start date: 2022-09-28
Primary completion: 2025-08-28
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.